Local drug makers to be hit by patent suits

Published: 2012-03-19 07:00:00

Updated: 2012-03-19 07:00:00

Korean drug firms would face an uphill battle in patent infringement lawsuits as the Korea-U.S. free trade agreement (KORUS FTA) went into effect Thursday, citing the need for effective policy to support them.

According to data released by the Korean Intellectual Property Office and the Korea...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK